Browse Category

TWSE:2454.TW News 18 January 2026 - 2 February 2026

MediaTek stock heads into Monday with Feb. 4 results call in focus after Friday dip

MediaTek stock heads into Monday with Feb. 4 results call in focus after Friday dip

MediaTek shares fell 1.1% to NT$1,760 on Friday, trading 11.2 million shares between NT$1,735 and NT$1,775. Domestic investment trusts net bought 403,588 shares on Jan. 30. Investors await the company’s fourth-quarter results on Feb. 4 and January revenue figures on Feb. 10. The TAIEX index closed down 1.45% earlier in the week, adding pressure to tech stocks.
MediaTek stock price: Taiwan chipmaker in focus before open after 1.3% drop

MediaTek stock price: Taiwan chipmaker in focus before open after 1.3% drop

MediaTek shares fell 1.33% to T$1,485 Monday, underperforming as Taiwan’s benchmark index closed at 31,639.29 near record highs. Around 5.9 million MediaTek shares changed hands. Global markets slipped after U.S. President Trump announced new tariffs on European goods starting Feb. 1. Micron agreed to buy Powerchip’s P5 fab in Taiwan for $1.8 billion, aiming to boost DRAM output by 2027.

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Go toTop